Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» NYC Comptroller blasts Mylan’s board for ‘weak oversight’ and hurting shareholders
NYC Comptroller blasts Mylan’s board for ‘weak oversight’ and hurting shareholders
NYC Comptroller blasts Mylan’s board for ‘weak oversight’ and hurting shareholders
Submitted by
admin
on September 5, 2016 - 10:07am
Source:
Stat
News Tags:
Mylan Labs
EpiPen
shareholders
Headline:
NYC Comptroller blasts Mylan’s board for ‘weak oversight’ and hurting shareholders
Do Not Allow Advertisers to Use My Personal information
